Navigation Links
Real Time Genomics® Announces Platform Launch, Expanding Commercial Operations
Date:2/20/2013

lication of our technology. Our collaborators and Early Access customers have signed on because our combination of accuracy and speed is of great value to researchers looking to discover disease-associated variants and to the medical geneticists who interpret them for clinical use. Our technology roadmap will further leverage this value as we focus on continued improvements to accuracy and speed of analysis, allowing our platform to impact other critical disease applications.”

The Real Time Genomics platform takes raw sequence data, aligns it to a reference genome and accurately detects variants. The platform is compatible with data from a number of sequencing platforms, including Illumina, Ion Torrent, 454, and PacBio. In the case of family and trio studies, the platform simultaneously analyzes the genomic data from the related individuals within a proprietary Bayesian algorithmic framework that uses the rules of genetics (Mendel’s laws) to accurately identify variants across the individuals analyzed. The result is a report that includes single nucleotide and multiple nucleotide variants, small insertions and deletions, and structural variants. The platform can analyze whole genomes, exomes and targeted sequence regions in an order-of-magnitude less time than alternative open source methods. The platform can be imbedded locally into existing infrastructure, accessed on-demand in Amazon’s public cloud, or offered as a professional service by staff scientists. The company announced there will be both annual subscription pricing as well as pay-per-use pricing.

About Real Time Genomics, Inc.
Real Time Genomics (http://www.realtimegenomics.com) has a passion for genomics. The company offers software tools and applications for the extraction of unique value from genomic data. Its competency lies in applying the combination of its patented core technology and deep com
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Store-A-Tooth™ Stem Cell Banking Announces Appointment of Dedicated Sales Representative in New England
2. Ingenuity Systems Announces Curation of All Human Disease Implicated Genetic Variation
3. Adeptia Announces 75% Revenue Increase for 2012 Calendar Year
4. Japan Bioinformatics Announces the Release of their Simbiot® Time Course Analysis ‘How-To’ Guide
5. How To Get Rid of Bed Bugs Complete Extermination Guidelines Released By My Cleaning Products, Company Announces It's Also Giving Out Samples of Its Bed Bug Spray
6. AbbVie Declares Dividend and Announces Share Repurchase Program
7. Cepheid Announces Board of Directors Changes
8. Cellular Biomedicine Group Announces ISO 9001:2008 Certification and ISO-14644 Cleanroom Certification
9. Ingenuity Systems Announces Compliance with HIPAA
10. Rigaku Announces Method for Quantitative Elemental Analysis of Low-Alloy Steel with the Rigaku ZSX Primus III+ WDXRF Spectrometer
11. Chemir Announces New Custom Synthesis Laboratory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Oven Industries Inc. announces a new ... 5R6-900 benchtop controller has many outstanding user-friendly benefits. Contained ... into the wall as a self-contained temperature control system, ... makes the device unique, as well as highly convenient ... can also be used universally, which allows the user ...
(Date:5/20/2013)... , May 20, 2013  (PSHR) Pacific Shore ... based products across a broad range of product ... retained investor relations firm, BlueWater Advisory Group, to ... to trading process, and to direct the company,s ... Matthew Mills , ...
(Date:5/20/2013)... With bed bugs' presence come problems in various terms. ... to be eliminated, one must make sure that the bed ... so to help bed bug sufferers get that done, it ... bugs without using harmful pesticides. In it, the company ... Bug Bully. , According to My Cleaning Products, contrary to ...
(Date:5/20/2013)... 2013   Flexion Therapeutics , Inc. today announced ... to its management team as chief financial officer. ... management experience with biotechnology and medical device companies. ... financial officer for Novavax (NASDAQ: NVAX ) ... $250 million through a combination of investment funding and ...
Breaking Biology Technology:New Laboratory Temperature Controller by Oven Industries 2Pacific Shore Holdings Retains Investor Relations Firm 2New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2
... Incorporated,(Nasdaq: GPRO ) announced today that the Company ... on Tuesday, September 9,2008 at approximately 2:45 p.m. Eastern ... may be accessed through a link on the investors,section ... be available for 30 days following the event., ...
... during industry-leading event September 10 - 11, ... 2008 ... Plexus Systems, Inc.,provider of Plexus Online on-demand software for the ... 10-11, 2008 at the San Jose McEnery Conference Center, San ...
... The 33rd ESMO Congress,in Stockholm, the premier European ... medical oncologists, as well as a focal point ... The Congress Centre will be the venue for ... discuss critical issues for,European oncology such as cancer ...
Cached Biology Technology:Gen-Probe to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference 2Plexus Systems, Inc. to Exhibit at BIOMEDevice Medical Technology Conference 233rd ESMO Congress in Stockholm, 12-16 September 2008 233rd ESMO Congress in Stockholm, 12-16 September 2008 333rd ESMO Congress in Stockholm, 12-16 September 2008 433rd ESMO Congress in Stockholm, 12-16 September 2008 5
(Date:5/20/2013)... - A National Science Foundation (NSF) planning grant will ... (CARD), a joint program of the University of Illinois ... Mass. , "CARD will be devoted to research in ... agricultural products; forestry and paper products; chemical products; textiles; ... professor of food science and human nutrition and the ...
(Date:5/19/2013)... A novel study reports that white men and women ... bunions (hallux valgus) and lesser toe deformities, including hammer ... first to estimate the heritability of foot disorders in ... journal published by Wiley on behalf of the American ... that as many as 60% of older adults have ...
(Date:5/18/2013)... Research presented today at Digestive Disease Week (DDW) explores ... the impact of coffee on autoimmune disease and palliative ... recently has been associated with reduced risk of fibrosis, ... cups of java each month also correlate with lower ... the Mayo Clinic, Rochester, MN, linked coffee consumption with ...
Breaking Biology News(10 mins):NSF approves planning grant for Center for Advanced Research in Drying 2Blame your parents for bunion woes 2Coffee consumption associated with reduced risk of autoimmune liver disease 2
... blood clot-dissolving medication that is administered to some patients ... reduce the risk of amputation following severe frostbite, according ... of Surgery, one of the JAMA/Archives journals. , Frostbite ... 25 years, according to background information in the article. ...
... the University of Central Florida is proving promising as ... disease that can cause blindness and affects millions of ... the blood-brain barrier making it an effective non-toxic tool ... with appointments in UCF’s Advanced Materials Processing and Analysis ...
... A major obstacle in the treatment of infections and ... which prevents systemically delivered therapeutic drugs from reaching the ... Infectious Diseases, part of the National Institutes of Health, ... the rabies virus can carry a strip of therapeutic ...
Cached Biology News:Clot-dissolving agent may be beneficial in treatment of severe frostbite 2UCF nanoparticle offers promise for treating glaucoma 2Blood-brain barrier breached by new therapeutic strategy 2
Request Info...
... are functionally defined by their capacity to ... into multiple specialized progenitor cells, which can ... Neural stem cells (NSCs) are capable of ... neurons and oligodendrocytes. During the isolation and ...
Mouse monoclonal [B314.1 (MAC 387)] to Macrophage L1 protein Calprotectin (rating: ****) ( Abpromise for all tested applications)....
Anti Human JAM-1, Monoclonal Antibody, Clone M.Ab.F11...
Biology Products: